| Literature DB >> 25707370 |
Inês Guerra Pereira1, Paula Vaz2, Ricardo Faria Almeida3, Ana Cristina Braga4, António Felino5.
Abstract
OBJECTIVES: This study aimed to evaluate whether a specific interleukin-1 receptor-associated kinase-4 (IRAK4) gene polymorphism had any influence on the development of changes in maxillary sinus, particularly in the presence of etiological factors of dental origin.Entities:
Keywords: Genetic polymorphism; Genetic predisposition; IRAK-4 human protein; Maxillary sinusitis
Mesh:
Substances:
Year: 2015 PMID: 25707370 PMCID: PMC4592703 DOI: 10.1007/s00784-015-1424-5
Source DB: PubMed Journal: Clin Oral Investig ISSN: 1432-6981 Impact factor: 3.573
Fig. 1Sequencing image revealing a IRAK4 gene polymorphism, translated by two peaks, indicated by the arrow and identified in a recruited patient study
Primers used to detect the SNP on the IRAK4 human gene [Ref Seq: NM_016123]
| Primer | Sequence |
|---|---|
| IRAK4-3D | TGTAAAACGACGGCCAGTAAAGGAAGCAAACCCAGAGG |
| IRAK4-3U | CAGGAAACAGCTATGACCGGGAACCACAGCAAAGGTG |
| IRAK4-4D | TGTAAAACGACGGCCAGTGCCTCTCGATCTTGGACTTCC |
| IRAK4-4U | CAGGAAACAGCTATGACCCACAGTGTCCTTTGTCTGTGC |
| IRAK4-5D | TGTAAAACGACGGCCAGTCTCTGATATAGGTGGCTCATGG |
| IRAK4-5U | CAGGAAACAGCTATGACCTGCCTGTGATTGCTGCAC |
| IRAK4-6D | TGTAAAACGACGGCCAGTGTTCAGAGGGTAGGATCACC |
| IRAK4-6U | CAGGAAACAGCTATGACCGGTAGGGTCCATAGTGTTCAAC |
| IRAK4-7D | TGTAAAACGACGGCCAGTATGGGCCTTGAGCAAATCAC |
| IRAK4-7U | CAGGAAACAGCTATGACCCCTGTAGGTCCAGCTACTCG |
| IRAK4-8D | TGTAAAACGACGGCCAGTGGCTGAAAAGAGAAGTATTTGC |
| IRAK4-8U | CAGGAAACAGCTATGACCAATGGCAACCCAGTTGTTG |
| IRAK4-9D | TGTAAAACGACGGCCAGTATCATCTTCAGTTGTTGCCTAG |
| IRAK4-9U | CAGGAAACAGCTATGACCGAGCTTTCATGGAGTGATGG |
| IRAK4-10D | TGTAAAACGACGGCCAGTAAAGAGGACAGTTGCTTCTC |
| IRAK4-10U | CAGGAAACAGCTATGACCCCCACACCTATCTCTTGCTC |
| IRAK4-11D | TGTAAAACGACGGCCAGTATCTGTCTCCCAAAGTGCTG |
| IRAK4-11U | CAGGAAACAGCTATGACCCTGTCGTGTAATAGCCAATGG |
| IRAK4-12D | TGTAAAACGACGGCCAGTGAGCACATGTTATTACAAAGTAG |
| IRAK4-13U | CAGGAAACAGCTATGACCGTGTTTCCACCCTACATACAG |
Fig. 2Illustration of the statistical association between the presence of IRAK4 gene polymorphism (positive genetic test) and the presence of the mucosal thickening of maxillary sinus on computed tomography image
Fig. 3Relation between the IRAK4 gene polymorphism (positive genetic test) and maxillary sinusitis of odontogenic origin
Results of the Fisher exact test for association between the IRAK4 gene polymorphism and patient symptoms
| Patient symptoms |
|
|---|---|
| Headache | 0.426 |
| Mucopurulent drainage | 0.342 |
| Nasal obstruction | 0.393 |
| Decreased sense of smell | 0.525 |
| Ear pain | 0.478 |
| Dental pain | 0.331 |
Results of the Fisher exact test for association between the IRAK4 gene polymorphism and the evaluated parameters in the physical examination
| Physical examination |
|
|---|---|
| Palpation pain | 0.220 |
| Edema | 0.389 |
| Erythema | 0.283 |
Results of Fisher exact test for association between the medication and the presence of IRAK4 gene polymorphism
| Medication |
|
|---|---|
| Anticoagulants | 0.457 |
| Corticosteroids | 0.489 |
| Antihypertensives | 0.18 |
| Anti-depressants | 0.606 |
| Antibiotics | 0.604 |
| Anti-inflammatory | 0.17 |
Age distribution according to diagnosis in the final sample
| Diagnostic | ||||
|---|---|---|---|---|
| Healthy | Odontogenic sinusitis | Total | ||
| Age (years) | Mean | 42.0 | 42.8 | 42.5 |
| Median | 41.5 | 43.5 | 42.0 | |
| Standard deviation | 15.9 | 14.0 | 14.8 | |
| Minimum | 18.0 | 18.0 | 18.0 | |
Univariate logistic regression
| Variables |
| S.E. | Wald | df | Sig. | Exp (B) |
|---|---|---|---|---|---|---|
| Gender | 0.123 | 0.446 | 0.076 | 1 | 0.782 | 1.131 |
| Family history of maxillary sinusitis | 1.959 | 0.797 | 6.042 | 1 | 0.014* | 7.091 |
| Motive of dental appointment | 0.916 | 0.453 | 4.088 | 1 | 0.043* | 2.500 |
| Maxillary sinusitis | 2.982 | 1.060 | 7.921 | 1 | 0.005* | 19.733 |
| Allergic rhinosinusitis | 2.330 | 1.075 | 4.701 | 1 | 0.030* | 10.278 |
| Diabetes | −0.951 | 0.896 | 1.127 | 1 | 0.288 | 0.386 |
| Tobacco | 0.730 | 0.591 | 1.522 | 1 | 0.217 | 2.074 |
| Headache | 2.356 | 0.788 | 8.939* | 1 | 0.003* | 10.552 |
| Pressure | 3.169 | 1.057 | 8.981* | 1 | 0.003* | 23.786 |
| Ear pain | 21.285 | 12,118.636 | 0.000 | 1 | 0.999# | 1,753,944,115.096 |
| Mucopurulent drainage | 1.878 | 0.607 | 9.584 | 1 | 0.002* | 6.538 |
| Decreased sense of smell | 21.375 | 10,742.023 | 0.000 | 1 | 0.998# | 1,918,376,375.886 |
| Dental pain | 21.314 | 11,602.711 | 0.000 | 1 | 0.999# | 1,805,530,706.716 |
| Pain on percussion | 21.375 | 10,742.023 | 0.000 | 1 | 0.998# | 1,918,376,375.886 |
| Pain on palpation | 2.330 | 1.075 | 4.701* | 1 | 0.030* | 10.278 |
| Swelling/tumefaction | 21.285 | 12,118.636 | 0.000 | 1 | 0.999# | 1,753,944,115.096 |
| Erythema | 21.079 | 23,205.422 | 0.000 | 1 | 0.999# | 1,427,628,930.892 |
| Dentate behaviour on CT (computed tomography) | −21.476 | 23,205.422 | 0.000 | 1 | 0.999# | 0.000 |
| Maxillary sinus communication | 2.606 | 0.552* | 22.248 | 1 | 0.000* | 13.538 |
| Dental implants | 21.152 | 16,408.711 | 0.000 | 1 | 0.999# | 1,534,701,100.709 |
| Dental decay | 21.056 | 28,420.721 | 0.000 | 1 | 0.999# | 1,395,182,818.826 |
| Periodontal disease | 21.103 | 20,096.485 | 0.000 | 1 | 0.999# | 1,461,620,095.913 |
| Periapical lesion | 21.545 | 9220.900 | 0.000 | 1 | 0.998# | 2,273,631,260.309 |
| Endodontic treatment | 21.545 | 9220.900 | 0.000 | 1 | 0.998# | 2,273,631,260.309 |
| Cysts | 21.177 | 15,191.515 | 0.000 | 1 | 0.999# | 1,574,052,410.983 |
| Oroantral fistula | 21.034 | 40,192.969 | 0.000 | 1 | 1.000# | 1,364,178,756.185 |
| Impacted teeth | 21.406 | 10,377.780 | 0.000# | 1 | 0.998# | 1,980,259,484.785 |
| Foreign bodies | 21.034 | 40,192.969 | 0.000# | 1 | 1.000# | 1,364,178,756.185 |
| Radiopacity | 22.068 | 7338.199 | 0.000# | 1 | 0.998# | 3,836,752,751.771 |
| Presence of air fluid | 21.152 | 16,408.711 | 0.000# | 1 | 0.999# | 1,534,701,100.709 |
| Mucosal thickening | 24.147 | 6059.318 | 0.000# | 1 | 0.997# | 30,694,022,014.172 |
| Cortical bone loss | 4.240 | 1.060 | 16.007 | 1 | 0.000* | 69.375 |
| Implant lesion | 21.079 | 23,205.422 | 0.000 | 1 | 0.999# | 1,427,628,930.892 |
| Genetic test | 0.970 | 0.498 | 3.797 | 1 | 0.051* | 2.639 |
*Indicates that there is a statistically significant association of this variable with the diagnosis groups
#Indicates instability due to the high value of the standard error, and was not considered for analysis
Variables in the equation resulted from forward conditional stepwise
| Variables |
| S.E. | Wald | Df |
| Exp (B) |
|---|---|---|---|---|---|---|
| Diagnosed sinusitis | 2.341 | 1.257 | 3.471 | 1 | 0.062 | 10.396 |
| Nasal congestion | 2.367 | 1.248 | 3.596 | 1 | 0.058 | 10.666 |
| Cortical bone loss | 3.635 | 1.202 | 9.146 | 1 | 0.002 | 37.898 |
|
| 1.239 | 0.745 | 2.765 | 1 | 0.096 | 3.453 |
| Maxillary sinus communication | 1.010 | 0.833 | 1.470 | 1 | 0.225 | 2.745 |
| Constant | −2.121 | 0.564 | 14.139 | 1 | 0.000 | 0.120 |
B estimates for the slope coefficients of the univariate logistic regression model containing only this variable, S.E. the estimated standard error for the coefficient of the slope, Df degree of freedom, Wald Wald statistic, Exp (B) estimates for odds ratio
Fig. 4Empirical ROC curve to the decision model